Literature DB >> 4174095

[Quantitative studies in rats on the resistance of various organs to inoculated tumor cells].

D Schmähl, H Osswald, L Prochotta.   

Abstract

Entities:  

Mesh:

Year:  1967        PMID: 4174095

Source DB:  PubMed          Journal:  Z Krebsforsch        ISSN: 0301-1585


× No keyword cloud information.
  5 in total

1.  [THE INFLUENCE OF PRELIMINARY TREATMENT OF RATS WITH ALKYLATING SUBSTANCES AND OTHER TOXINS ON THE GROWTH OF YOSHIDA SARCOMA].

Authors:  D SCHMAEHL; W SATTLER
Journal:  Arzneimittelforschung       Date:  1964-07

2.  [Experimental studies on metastasis formation of tumors in rats].

Authors:  D SCHMAHL; T RIESEBERG
Journal:  Z Krebsforsch       Date:  1958

3.  [CELLULAR MULTICENTRICITY OF CARCINOGENESIS. STUDIES ON THE RAT ASCITES HEPATOMA].

Authors:  T YOSHIDA
Journal:  Dtsch Med Wochenschr       Date:  1963-11-15       Impact factor: 0.628

4.  [Quantitative transplantation experiments with the Yoshida ascites sarcoma in rats].

Authors:  D SCHMAHL; R MECKE
Journal:  Z Krebsforsch       Date:  1955

5.  [Experimental investigations of the metastasis of Yoshida sarcoma].

Authors:  D Schmähl; H Osswald; C Thomas
Journal:  Z Krebsforsch       Date:  1965
  5 in total
  3 in total

1.  [Experimental investigations about the chemosensibility of transplantation tumors at different sites of transplantation].

Authors:  E Holst; U Sievers; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1971

2.  Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.

Authors:  M Habs; H Reinbold; G Eisenbrand; S Bhide; S Goga-Ionescu; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

3.  Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations.

Authors:  G Eichler; M Habs; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.